Skip to content
PubMed This is a summary of 46 peer-reviewed journal articles Updated
Immunology

Predisposition to invasive fungal disease due to CARD9 deficiency: A Patient Guide

At a Glance

CARD9 deficiency is an inherited immune-system disorder that can cause serious, slow-developing fungal infections in the skin, bones, brain, or spinal cord. Genetic testing confirms the diagnosis, and prolonged antifungal treatment with specialist monitoring may reduce relapse risk.

This guide provides educational information; your immunologist and infectious-disease clinician will determine your specific treatment, prophylaxis, imaging, and laboratory schedules. It is highly recommended to keep a written emergency plan and medication list with you at all times.

Predisposition to invasive fungal disease due to CARD9 deficiency is a rare, inherited condition that creates a highly specific vulnerability or “blind spot” in the immune system. While most people with this condition are otherwise healthy and effectively fight off common viruses and bacteria, their bodies struggle to recognize and respond to certain types of fungi [1]. This is because the CARD9 protein acts as a critical messenger that tells the immune system to launch an attack when a fungus is detected; without it, the alarm may fail to sound, and the body can fail to recruit the necessary defenses [2].

This specific immune defect can lead to deep, invasive fungal infections that move beyond the surface of the skin and into vital organs like the brain, spinal cord, or bones [1]. These are not typical superficial issues like athlete’s foot or a simple yeast infection; they are severe, potentially life-threatening illnesses such as CNS candidiasis (fungal infection of the brain), deep dermatophytosis (deep skin and bone infection), or phaeohyphomycosis (infections caused by certain molds) [3]. Because the body’s natural warning systems can be muted, these infections can develop slowly and may go unnoticed until they have caused significant damage [4].

Diagnosing CARD9 deficiency is often a challenge because a patient’s routine immune blood work—such as white blood cell counts and antibody levels—typically looks completely normal [5]. The immune system has the “soldiers” it needs, but they simply aren’t receiving their orders to fight fungi. Consequently, a definitive diagnosis requires specialized genetic testing to identify mutations in both copies of the CARD9 gene [6]. This genetic root also means the condition is autosomal recessive, meaning it is passed down through families. It is common for symptoms to first appear in childhood, but the condition can also remain “hidden” until late adulthood, with first infections reported in people as old as 91 [3].

Living with this condition requires a long-term, proactive strategy focused on both treatment and prevention. Because the body’s defense pathways for clearing these fungi are impaired, patients often require exceptionally long courses of powerful antifungal medications—sometimes lasting a year or more—to ensure an infection is fully controlled [7]. Even after an infection seems to have cleared, the risk of it returning can be high. Depending on the infection site, organism, and response, this sometimes necessitates long-term “suppressive” therapy to prevent a relapse [1].

Because of the inherited nature of the disease, it is also standard practice to recommend genetic counseling and cascade testing for a patient’s siblings. Siblings may carry the same genetic profile and be at risk for future infections even if they currently feel perfectly healthy [6]. Although the diagnosis requires lifelong vigilance, an accurate understanding of this specific immune defect allows for targeted care that can effectively manage the risk and protect long-term health [8].

Common questions in this guide

What does CARD9 deficiency mean for my risk of fungal infections?
CARD9 deficiency is an inherited immune-system problem in which the body has trouble recognizing and responding to certain fungi. It can allow infections to move beyond the skin and affect areas such as the brain, spinal cord, or bones, even when common immune blood tests look normal.
Which fungal infections are linked to CARD9 deficiency?
Affected people can develop serious infections such as brain candidiasis, deep dermatophytosis, and phaeohyphomycosis. These infections may progress slowly and can involve the skin, bones, brain, or other deep tissues.
Can standard immune blood tests miss CARD9 deficiency?
Yes. White blood cell counts and antibody levels are often normal because the problem affects a specific immune message used to respond to fungi. Specialized genetic testing looks for changes in both copies of the CARD9 gene.
Is CARD9 deficiency inherited, and should my siblings be tested?
Yes. It is autosomal recessive, meaning a person inherits altered copies of the CARD9 gene from both parents, and siblings may carry the same genetic profile even if they feel healthy. Genetic counseling and family testing can help determine which relatives should be tested.
How long might antifungal treatment last with CARD9 deficiency?
Treatment often requires an unusually long course of antifungal medicine, sometimes a year or more. If the infection could return, a specialist may recommend ongoing suppressive treatment after the initial infection appears controlled.
What ongoing monitoring is needed for CARD9 deficiency?
Monitoring may include regular imaging and blood tests directed by specialists, even when you feel well. The schedule should be individualized to your infection history and treatment response, and keeping a written emergency plan and medication list can support safe care.

Get notified when new evidence is published on Predisposition to invasive fungal disease due to CARD9 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults.

    Corvilain E, Casanova JL, Puel A

    Journal of clinical immunology 2018; (38(6)):656-693 doi:10.1007/s10875-018-0539-2.

    PMID: 30136218
  2. 2

    Mechanistic Insights into the Role of C-Type Lectin Receptor/CARD9 Signaling in Human Antifungal Immunity.

    Drummond RA, Lionakis MS

    Frontiers in cellular and infection microbiology 2016; (6()):39 doi:10.3389/fcimb.2016.00039.

    PMID: 27092298
  3. 3

    Clinical features of patients with fungal infections caused by CARD9 deficiency: a literature review of case reports.

    Tang C, Liu Y, Long J, Lv X

    Frontiers in cellular and infection microbiology 2025; (15()):1615929 doi:10.3389/fcimb.2025.1615929.

    PMID: 40740345
  4. 4

    [CARD9 Mutation in a Patient with Candida albicans Meningoencephalitis; A Case Report].

    Kuruoğlu T, Çelik M, Çelmeli F, Tanyel E

    Mikrobiyoloji bulteni 2021; (55(4)):656-664 doi:10.5578/mb.20219717.

    PMID: 34666665
  5. 5

    Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.

    Rieber N, Gazendam RP, Freeman AF, et al.

    JCI insight 2016; (1(17)):e89890.

    PMID: 27777981
  6. 6

    Inherited CARD9 Deficiency in a Child with Invasive Disease Due to Exophiala dermatitidis and Two Older but Asymptomatic Siblings.

    Imanaka Y, Taniguchi M, Doi T, et al.

    Journal of clinical immunology 2021; (41(5)):975-986 doi:10.1007/s10875-021-00988-7.

    PMID: 33558980
  7. 7

    Chronic Candida albicans Meningitis in a 4-Year-Old Girl with a Homozygous Mutation in the CARD9 Gene (Q295X).

    Herbst M, Gazendam R, Reimnitz D, et al.

    The Pediatric infectious disease journal 2015; (34(9)):999-1002 doi:10.1097/INF.0000000000000736.

    PMID: 25933095
  8. 8

    Successful Allogenic Stem Cell Transplantation in Patients with Inherited CARD9 Deficiency.

    Queiroz-Telles F, Mercier T, Maertens J, et al.

    Journal of clinical immunology 2019; (39(5)):462-469 doi:10.1007/s10875-019-00662-z.

    PMID: 31222666

This page is for informational purposes only and does not constitute medical advice. Your immunologist and infectious-disease clinician should tailor genetic testing, antifungal treatment, prophylaxis, and monitoring to your situation.